𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Purinergic signalling: Therapeutic potential

✍ Scribed by Geoffrey Burnstock

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
105 KB
Volume
45
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

✦ Synopsis

This article begins with a brief review of the current status of receptor subtypes for purines and pyrimidines. It then focuses on pathophysiological roles of ATP and discusses some related therapeutic possibilities. Finally, the expanding field of purinergic signalling in embryology is introduced.

📜 SIMILAR VOLUMES

Purinergic signalling: Its unpopular beg
Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future
✍ Geoffrey Burnstock 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

## Abstract Adenosine 5′‐triphosphate (ATP) was identified in 1970 as the transmitter responsible for non‐adrenergic, non‐cholinergic neurotransmission in the gut and bladder and the term ‘purinergic’ was coined. Purinergic cotransmission was proposed in 1976 and ATP is now recognized as a cotransm

TNAP, TrAP, ecto-purinergic signaling, a
TNAP, TrAP, ecto-purinergic signaling, and bone remodeling
✍ Jonathan D. Kaunitz; Dean T. Yamaguchi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

## Abstract Bone remodeling is a process of continuous resorption and formation/mineralization carried out by osteoclasts and osteoblasts, which, along with osteocytes, comprise the bone multicellular unit (BMU). A key component of the BMU is the bone remodeling compartment (BRC), isolated from the

Altered purinergic signaling in CD73-def
Altered purinergic signaling in CD73-deficient mice inhibits tumor progression
✍ Gennady G. Yegutkin; Fumiko Marttila-Ichihara; Marika Karikoski; Jussi Niemelä; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB

## Abstract CD73/ecto‐5′‐nucleotidase dephosphorylates extracellular AMP into adenosine, and it is a key enzyme in the regulation of adenosinergic signaling. The contribution of host CD73 to tumor growth and anti‐tumor immunity has not been studied. Here, we show that under physiological conditions